OTCPicks.com: OTCPicks.com Stocks to Watch for Friday, November 14th RCCH, ANVH, VNBC, ISTA

Fri. November 14, 2008; Posted: 04:46 AM

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

RCC HOLDINGS CORPORATION (OTC: RCCH | Quote | Chart | News | PowerRating) "Up 100.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/RCCH.php

RCC Holdings Corp. operates through its subsidiaries and provides information technology services. The company offers services such as software development, LAN and WAN integration, wireless broadband engineering, and Web design and marketing. RCC Holdings Corp. was previously known as CLIX Group, Inc. it is based in Kissimmee, Florida.

RCCH News:

November 12 - RCC Holdings Corp Completes Acquisition

RCC Holdings Corp. (OTC: RCCH | Quote | Chart | News | PowerRating) announces completion of its latest sole subsidiary acquisition: Ezee Debt Solutions, a company specializing in Loan Modification. Ezee Dept Solution will be located at RCC Holdings Corp office in California.

RCCIWS has made significant progress in the last month on its affordable housing initiative. The company has tailored its system to be user-friendlier and applicable to lower cost alternatives that affordable housing requires. The worldwide demand for affordable housing is growing at an exponential rate, and the early entry into this market is seen to be a major future outlet for the IWS wastewater treatment systems.

Pertinent to this market, work has begun on completing the paperwork for an NSF (National Science Foundation) grant, to be submitted this year. If accepted, the project will be accomplished in conjunction with a leading U.S. University, which will provide the research and testing talent for the project. Several companies are involved and the testing will be directed at the development of new technologies that can greatly enhance the viability of affordable housing worldwide. IWS will be responsible for the water and wastewater portions of the product testing. Notification of acceptance for the grants is expected to be in early March 2009.

Within the next week, IWS will announce the introduction of its new website with information on how to access. It is in final editing stages now, and will provide interested parties with much more detailed information about the company, its products and its future direction.

THE ANVIRON HOLDING COMPANY (OTC: ANVH | Quote | Chart | News | PowerRating) "Up 52.94% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/ANVH.php

Anviron is a company dedicated to bringing to market "Clean Solutions to Complex Problems" by offering a wide range of biodegradable, environmentally friendly products and technologies that will substitute for many of the hazardous chemicals commonly used all over the world. For information about Anviron and its product offerings visit www.anviron.com.

ANVH News:

November 13 - Anviron Reports October Financial Results up 157% over Budget

The Anviron Holding Company (OTC: ANVH | Quote | Chart | News | PowerRating) ("Anviron"), a manufacturer and marketer of "Clean & Green" products and technology, announced financial results for the month ending October 31, 2008 were posted on www.pinksheets.com. The Company continues to post record revenue with October posting more than $1.65M and year to date numbers posting of $17.1 million and net profit of $6.75 million, or $0.06 per basic share.

Highlights:

* Record 1st Quarter Revenue of $12.6 million, up 20.1% from budget.

* October 2008 Revenue of $1.65M, up 157% from budget.

* Fourth consecutive quarter of positive operational growth and profits.

* Laboratory JV anticipated generating $15 million in annual sales for fiscal 2009.

* Signing of four new contracts for NuSoil sales for FYE 2009.

* NuSoil selected as technology of choice for reclamation of closed Mine operation.

* DustControl and RoadBinder lead product sales in Fiscal-Year 2009.

"Anviron continues to deliver outstanding results, posting our fourth consecutive quarter of profitability as well as positive operating cash flow. Revenue increased 157% over budget for the fiscal year 2009, reflecting the ongoing demand for our organic products," said Anviron COO Steve Young.

"Our expanding profits continue to attract attention in the public market, as demonstrated by continued coverage on the Emerging Issuer's website, www.emergingissuer.com. As we grow, the staff, board and management will continue to focus on our expanding business," said Marcie Corbin, CFO of Anviron. StockVest.com has just completed the presentation of Anviron at this year's Washington DC Money Show, November 6-8. For 30 years now, The Money Show has spearheaded the field of investment trade shows attracting tens of thousands and remains #1 in the nation today.

VINEYARD NATIONAL BANCORP (NASDAQ: VNBC | Quote | Chart | News | PowerRating) "Up 31.33% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/VNBC.php

Vineyard National Bancorp operates as the holding company for Vineyard Bank, National Association, which provides community banking services to businesses and individuals. It accepts non-interest bearing demand deposits, time deposits, savings deposits, certificates of deposit, negotiable order of withdrawal deposits, and money market deposits. The company also offers single family residential (SFR) luxury home construction loans; commercial construction loans, including loans for the construction of office buildings, retail space, churches, and multifamily/apartment projects; SFR tract construction loans; and commercial and residential real estate loans. In addition, it provides cash management services that comprise electronic deposit services; online banking services, including automated wire processing, electronic tax payments, electronic transfers, loan payments, bill payments, and account reconciliation; lockbox processing services; and positive pay service that allows business customers to review checks presented against accounts prior to disbursing funds. Further, the company offers courier services, ATMs, and kiosks; and exchange accommodator services. Vineyard National serves commercial businesses, commercial and residential real estate developers, retail community businesses, individuals, investors, and other local private and public organizations. As of December 31, 2007, it operated 16 full service banking centers in the communities of Chino, Corona, Covina, Crestline, Diamond Bar, Irvine, Irwindale, Lake Arrowhead, La Verne, Manhattan Beach, Rancho Cucamonga, San Diego, San Dimas, San Rafael, Upland, and Walnutin, California; and 3 regional financial centers in Orange, Los Altos, and Westlake Village, California. The company was founded in 1981 and is headquartered in Corona, California.

VNBC News:

November 12 - Vineyard National Bancorp Announces Signing of Stock Purchase Agreement

Vineyard National Bancorp (Nasdaq: VNBC | Quote | Chart | News | PowerRating) (the "company"), the parent company for Vineyard Bank, N.A. ("Vineyard"), and Vineyard Bancshares, Inc., a newly formed Minnesota corporation (the "buyer"), announced the signing of a stock purchase agreement (the "agreement") for the sale of all of the outstanding common stock of Vineyard to the buyer.

The buyer is a newly formed corporation organized by our Chairman, Doug Kratz. Mr. Kratz, who has over twenty years of executive leadership experience in the community banking industry, has served as the Chairman of the Board of the company and as a director of Vineyard since August 2008. The company formed a special committee of disinterested directors to review its strategic alternatives, including the potential transaction with Mr. Kratz. The special committee unanimously recommended approval of the transaction to the Board, and the Board has approved the transaction.

The closing of the transaction is subject to the condition that the buyer raise at least $125 million in financing of which it intends to inject approximately $100 million of the proceeds into Vineyard. The agreement is also subject to the receipt of regulatory approval and other customary closing conditions. The company will continue to solicit competing bids for the sale of Vineyard as permitted by the agreement. The company is able to accept a superior proposal from another bidder, subject to paying the buyer a break-up fee of $600,000 plus the reimbursement of its expenses.

The purchase price for Vineyard is up to $18 million, consisting of a payment at closing of $10 million and an additional $8 million payable in three years if certain conditions are satisfied. The company's senior lender has agreed to accept $9 million of the initial purchase price plus the right to receive all of the contingent payment as full satisfaction of the outstanding balance on the senior line of credit.

"This transaction is a significant step toward realization of the Board's goal of securing Vineyard's safety and soundness," stated Glen Terry, President & CEO of Vineyard. He added, "We are pleased that in spite of the severe turmoil in the capital markets, the special committee has succeeded in negotiating a transaction that continues to strengthen Vineyard, and to protect its depositors. We believe that this transaction represents the best alternative available to us in what are the most extreme financial circumstances in my memory. I look forward to continuing to work with Doug Kratz in rebuilding this important franchise."

ISTA PHARMACEUTICALS INCORPORATED (NASDAQ: ISTA | Quote | Chart | News | PowerRating) "Up 27.50% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/ISTA.php

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S.

ISTA News:

November 13 - ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve

ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the Company filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Bepreve (bepotastine ophthalmic solution). The Company is seeking approval for Bepreve as an eye drop treatment for ocular itching associated with allergic conjunctivitis.

ISTA filed the Bepreve NDA electronically, in eCTD format and using the FDA's Electronic Submission Gateway. Pending FDA validation of the electronic file in the coming days and timely acceptance of the filing by the FDA, ISTA expects a standard review of ten months from date of receipt.

In April of this year, ISTA announced highly statistically significant reductions in the primary study endpoint of ocular itching from the preliminary analysis of its second and final Bepreve Phase III clinical study. In addition, the results showed Bepreve had a statistically significant effect on the rapidity of response and in certain secondary endpoints measuring additional signs or symptoms of ocular allergy, including improvement in nasal symptoms. There were no serious ocular adverse events reported in patients dosed with Bepreve from the study.

ABOUT BEPREVE (BEPOTASTINE OPHTHALMIC SOLUTION)

Assuming both timely acceptance by the FDA of the Bepreve NDA for filing and approval to market, Bepreve would participate in the U.S. ocular allergy market, which had estimated 2007 sales of approximately $560 million based on data from IMS Health. Assuming approval, Bepreve would participate in ISTA's largest market to date, as compared to ISTA's currently marketed products.

Bepreve has three primary mechanisms of action: it is a non-sedating, highly selective antagonist of the histamine (H1) receptor, it has a stabilizing effect on mast cells, and it suppresses the migration into and activation of eosinophils in inflamed tissues. The compound's primary mechanisms of action are believed to make it an effective treatment against the signs and symptoms of allergic conjunctivitis.

Bepotastine was approved in Japan for use as a systemic drug in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively, and is marketed by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku Co., Ltd.) under the brand name TALION . TALION was co-developed by Tanabe Seiyaku and Ube Industries, Ltd., who discovered bepotastine. In 2001, Tanabe Seiyaku granted Senju Pharmaceutical Co., Ltd., exclusive worldwide rights, with the exception of certain Asian countries, to develop, manufacture and market bepotastine for ophthalmic use. In 2006, ISTA licensed the exclusive North American rights from Senju to an eye drop formulation of bepotastine for the treatment of allergic conjunctivitis.

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover's Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability:Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has not been compensated by any of the companies covered in this release. For a complete list of disclosures go to http://www.otcpicks.com/disclosure-details.htm. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor's sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party websites or access to third party content. OTCPicks.com does not control, endorse, or guarantee content found in such sites. You agree that OTCPicks.com is not responsible for any content, associated links, resources, or services associated with a third party site. You further agree that OTCPicks.com shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, OTCPicks.com Tel: +1 972 546 3740 e-mail: publisher@otcpicks.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details for ANVH click here.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index